Clinical Trials on HER2 Positive Advanced Solid Tumors in Canada
Total 468 results
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
University of AlbertaWithdrawnLocally Advanced Solid Tumors | Metastatic Solid TumorsCanada
-
Bristol-Myers SquibbCompletedAdvanced Solid Tumors | Metastatic Solid TumorsKorea, Republic of, Canada, Australia
-
AstraZenecaCompletedAdvanced Solid TumorsDenmark, Canada
-
Sunnybrook Health Sciences CentreUniversity of Toronto; Princess Margaret Hospital, CanadaRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...TerminatedAdvanced Solid TumorsUnited States, Canada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedAdvanced Solid TumoursCanada
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
Daiichi Sankyo Co., Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerJapan, United States, Canada
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
YM BioSciencesCIMYM BioSciencesCompleted
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, Canada, United Kingdom
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsCanada, United States, Denmark, Israel, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsChina, United States, Australia, Canada, Chile, Israel, Japan, Korea, Republic of, Panama, Poland, Spain, Switzerland, Turkey, New Zealand, Taiwan
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsCanada, United States, Spain, France, Switzerland
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Korea, Republic of, Belgium, Canada, Germany, Italy, Spain, United States, Hong Kong, Hungary, China, Czechia, Taiwan, France, Poland, Thailand, Netherlands
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced Solid TumorsUnited States, Canada
-
Hoffmann-La RocheCompletedAdvanced/Metastatic Solid TumorsUnited States, Belgium, Denmark, Spain, Netherlands, Canada, Italy
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
Repare TherapeuticsActive, not recruitingAdvanced Solid TumorUnited States, Canada, Spain, United Kingdom
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsCanada, United States, Argentina, France, Spain, Italy, Australia, Mexico, Chile
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Spanish Breast Cancer Research GroupSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Locally Advanced HER2 Positive Breast CarcinomaSpain
-
Gilead SciencesRecruitingAdvanced Solid TumorUnited States, Australia, Taiwan, Spain, Canada
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Merck Sharp & Dohme LLCCompletedAdvanced/Metastatic Solid TumorsUnited States, Canada
-
PrecirixTerminatedAdvanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care TreatmentUnited States, Canada
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsCanada, Switzerland, United States
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States, Canada
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsUnited States, Canada, Israel, Netherlands